• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

空腹血糖水平与腹膜透析患者全因和死因特异性死亡率的关系。

Fasting blood glucose level and risk of all-cause and cause-specific mortality in peritoneal dialysis patients.

机构信息

Division of Nephrology, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University, College of Medicine, Seoul, Republic of Korea.

Division of Nephrology, Department of Internal Medicine, Korea University, College of Medicine, Seoul, Republic of Korea.

出版信息

J Diabetes. 2024 Sep;16(9):e13601. doi: 10.1111/1753-0407.13601.

DOI:10.1111/1753-0407.13601
PMID:39264005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11391383/
Abstract

BACKGROUND

Glycemic control is crucial in peritoneal dialysis (PD) patients with diabetes. Although fasting blood glucose (FBG) is the most commonly used index to measure blood glucose levels, there is currently no evidence supporting the association between FBG level and mortality risk in PD patients.

METHODS

A total of 3548 diabetic PD patients between 2002 and 2018 were enrolled from the National Health Insurance Service database of Korea. We investigated the association between FBG levels and the risk of all-cause and cause-specific mortality.

RESULTS

Patients with FBG levels 80-99 mg/dL exhibited the highest survival rates, whereas those with FBG levels ≥180 mg/dL had the lowest survival rates. Compared with FBG levels 80-99 mg/dL, the adjusted hazard ratios and 95% confidence interval for all-cause mortality significantly increased as follows: 1.02 (0.87-1.21), 1.41 (1.17-1.70), 1.44 (1.18-2.75), and 2.05 (1.73-2.42) for patients with FBG 100-124 mg/dL, FBG 125-149 mg/dL, FBG 150-179 mg/dL, and FBG ≥180 mg/dL, respectively. The risk for all-cause mortality also showed an increasing pattern in patients with FBG levels <80 mg/L. The risk of cardiovascular death significantly increased as FBG levels exceeded 125 mg/dL. However, the risk of infection-related and malignancy-related deaths did not show a significant increase with increasing FBG levels.

CONCLUSION

There was an increase in the risk of all-cause mortality as FBG levels exceeded 125 mg/dL in PD patients with diabetes, and the risk of cardiovascular death showed a strong correlation with FBG levels compared with other causes of death.

摘要

背景

血糖控制对于接受腹膜透析(peritoneal dialysis,PD)治疗的糖尿病患者至关重要。尽管空腹血糖(fasting blood glucose,FBG)是最常用于测量血糖水平的指标,但目前尚无证据表明 FBG 水平与 PD 患者的死亡风险之间存在关联。

方法

本研究共纳入了 2002 年至 2018 年期间韩国国家健康保险服务数据库中的 3548 名患有糖尿病的 PD 患者。我们研究了 FBG 水平与全因和特定原因死亡率风险之间的关系。

结果

FBG 水平为 80-99mg/dL 的患者生存率最高,而 FBG 水平≥180mg/dL 的患者生存率最低。与 FBG 水平为 80-99mg/dL 的患者相比,FBG 水平为 100-124mg/dL、125-149mg/dL、150-179mg/dL 和≥180mg/dL 的患者发生全因死亡的调整后风险比和 95%置信区间分别显著升高(1.02[0.87-1.21]、1.41[1.17-1.70]、1.44[1.18-2.75]和 2.05[1.73-2.42])。FBG 水平<80mg/L 的患者发生全因死亡的风险也呈现出升高的趋势。当 FBG 水平超过 125mg/dL 时,心血管死亡的风险显著增加。然而,感染相关和恶性肿瘤相关死亡的风险并未随着 FBG 水平的升高而显著增加。

结论

在患有糖尿病的 PD 患者中,FBG 水平超过 125mg/dL 会增加全因死亡风险,与其他死亡原因相比,心血管死亡的风险与 FBG 水平具有很强的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecb/11391383/3778cdecfc99/JDB-16-e13601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecb/11391383/3778cdecfc99/JDB-16-e13601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecb/11391383/3778cdecfc99/JDB-16-e13601-g002.jpg

相似文献

1
Fasting blood glucose level and risk of all-cause and cause-specific mortality in peritoneal dialysis patients.空腹血糖水平与腹膜透析患者全因和死因特异性死亡率的关系。
J Diabetes. 2024 Sep;16(9):e13601. doi: 10.1111/1753-0407.13601.
2
Evaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes.评估糖尿病患者的血清葡萄糖水平与肾脏疾病进展。
JAMA Netw Open. 2021 Sep 1;4(9):e2127387. doi: 10.1001/jamanetworkopen.2021.27387.
3
Fasting blood glucose and the risk of all-cause mortality in patients with diabetes mellitus undergoing hemodialysis.糖尿病肾病血液透析患者的空腹血糖与全因死亡率风险
Kidney Res Clin Pract. 2024 Sep;43(5):680-689. doi: 10.23876/j.krcp.23.098. Epub 2024 Jan 26.
4
Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus.糖尿病腹膜透析患者的血糖控制与生存。
Clin J Am Soc Nephrol. 2011 May;6(5):1041-8. doi: 10.2215/CJN.08921010. Epub 2011 Apr 21.
5
Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea.血糖控制改变糖尿病初治透析患者中血液透析与腹膜透析之间死亡率风险的差异:韩国一项全国性前瞻性队列研究的结果
Medicine (Baltimore). 2016 Mar;95(11):e3118. doi: 10.1097/MD.0000000000003118.
6
Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan.台湾地区糖尿病前期(空腹血糖受损)人群的死亡风险增加。
Diabetes Care. 2005 Nov;28(11):2756-61. doi: 10.2337/diacare.28.11.2756.
7
Glycemic Control and Mortality in Diabetic Patients Undergoing Dialysis Focusing on the Effects of Age and Dialysis Type: A Prospective Cohort Study in Korea.糖尿病透析患者的血糖控制与死亡率:聚焦年龄和透析类型的影响——韩国一项前瞻性队列研究
PLoS One. 2015 Aug 18;10(8):e0136085. doi: 10.1371/journal.pone.0136085. eCollection 2015.
8
Optimal fasting glucose levels with regard to cardiovascular and mortality outcomes in people treated with or without antidiabetic medication.在使用或不使用抗糖尿病药物治疗的人群中,与心血管和死亡率结局相关的最佳空腹血糖水平。
Diabetes Obes Metab. 2020 Feb;22(2):243-253. doi: 10.1111/dom.13892. Epub 2019 Oct 31.
9
The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.空腹血糖变化对心肌梗死、卒中和全因死亡率风险的影响:一项全国性队列研究。
Cardiovasc Diabetol. 2018 Apr 7;17(1):51. doi: 10.1186/s12933-018-0694-z.
10
International variations in serum PTH and calcium levels and their mortality associations in peritoneal dialysis patients: Results from PDOPPS.腹膜透析患者血清 PTH 和钙水平的国际差异及其与死亡率的关系:PDOPPS 研究结果。
Perit Dial Int. 2024 Jul;44(4):275-286. doi: 10.1177/08968608241235516. Epub 2024 Mar 19.

引用本文的文献

1
Relationship between glucose to lymphocyte ratio and the first peritonitis episode in patients treated with peritoneal dialysis.接受腹膜透析治疗的患者中葡萄糖与淋巴细胞比值与首次腹膜炎发作之间的关系。
Sci Rep. 2025 Feb 26;15(1):6834. doi: 10.1038/s41598-025-91252-0.

本文引用的文献

1
Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate.肾小球滤过率水平与慢性肾脏病相关并发症和死亡率的性别差异。
Nephrol Dial Transplant. 2024 Nov 27;39(12):2005-2015. doi: 10.1093/ndt/gfae087.
2
Fasting blood glucose and the risk of all-cause mortality in patients with diabetes mellitus undergoing hemodialysis.糖尿病肾病血液透析患者的空腹血糖与全因死亡率风险
Kidney Res Clin Pract. 2024 Sep;43(5):680-689. doi: 10.23876/j.krcp.23.098. Epub 2024 Jan 26.
3
Changes in fasting blood glucose status and incidence of cardiovascular disease: The China-PAR project.
空腹血糖状态变化与心血管疾病发病风险:中国前瞻性研究。
J Diabetes. 2023 Feb;15(2):110-120. doi: 10.1111/1753-0407.13350. Epub 2023 Jan 13.
4
6. Glycemic Targets: Standards of Care in Diabetes-2023.6. 血糖目标:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
5
Glycated hemoglobin levels and risk of all-cause and cause-specific mortality in hemodialysis patients with diabetes.糖化血红蛋白水平与糖尿病血液透析患者全因和死因特异性死亡率的关系。
Diabetes Res Clin Pract. 2022 Aug;190:110016. doi: 10.1016/j.diabres.2022.110016. Epub 2022 Jul 21.
6
Long-term glycemic variability and the risk of mortality in diabetic patients receiving peritoneal dialysis.长期血糖变异性与接受腹膜透析的糖尿病患者死亡风险的关系。
PLoS One. 2022 Jan 25;17(1):e0262880. doi: 10.1371/journal.pone.0262880. eCollection 2022.
7
6. Glycemic Targets: Standards of Medical Care in Diabetes-2022.6. 血糖目标:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S83-S96. doi: 10.2337/dc22-S006.
8
Peritoneal Dialysis.腹膜透析
N Engl J Med. 2021 Nov 4;385(19):1786-1795. doi: 10.1056/NEJMra2100152.
9
Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression.18 项心血管结局试验中血糖控制的改善和主要心血管事件的减少:更新的荟萃回归分析。
Cardiovasc Diabetol. 2021 Oct 18;20(1):210. doi: 10.1186/s12933-021-01401-8.
10
Management of diabetes mellitus in dialysis patients: Obstacles and challenges.透析患者糖尿病的管理:障碍和挑战。
Diabetes Metab Syndr. 2021 May-Jun;15(3):1025-1036. doi: 10.1016/j.dsx.2021.05.007. Epub 2021 May 10.